Establishment of a model of penicillin-resistant Streptococcus pneumoniae pneumonia in healthy CBA/J mice

Journal of Medical Microbiology

Volumn 45, Issue 5, 1996, Pages 319-322

  Takashima, K ^a,b   Tateda, K ^a   Matsumoto, T ^a   Ito, T ^b   Iizawa, Y ^b   Nakao, M ^b   Yamaguchi, K ^a  

^a TOHO UNIVERSITY   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HISTOPATHOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 0029807209     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-45-5-319     Document Type: Article

References (12)

1. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1: 671-674.
2. Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis 1990; 142: 369-373.
3. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83.
4. Baquero F, Martínez-Beltrán J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991; 28 Suppl C: 31-38.
5. Liñares J, Alonso T, Pérez JL et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J Antimicrob Chemother 1992; 30: 279-288.
6. Azoulay-Dupuis E, Vallée E, Veber B, Bédos JP, Bauchet J, Pocidalo J-J. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrob Agents Chemother 1992; 36: 2698-2703.
7. Moine P, Vallée E, Azoulay-Dupuis E et al. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob Agents Chemother 1994; 38: 1953-1958.
8. Boulnois GJ. Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae. J Gen Microbiol 1992; 138: 249-259.
9. Briles DE, Horowitz J, McDaniel LS et al. Genetic control of the susceptibility to pneumococcal infection. Curr Top Microbiol Immunol 1986; 124: 103-120.
10. Japanese Society for Chemotherapy. Determination of minimum inhibitory concentration (MIC) by the micro-dilution method. Chemotherapy 1990; 38: 102-105.
11. Briles DE, Crain MJ, Gray BM, Forman C, Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 1992; 60: 111-116.
12. Johnston RB. Pathogenesis of pneumococcal pneumonia. Rev infect Dis 1991; 13 Suppl 6: S509-S517.